You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 169 No. 8, April 27, 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Invited Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Treatment Adherence
 •Drug Therapy
 •Adherence
 •Drug Therapy, Other
 •Endocrine Diseases
 •Diabetes Mellitus
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill—Invited Commentary

Sumit R. Majumdar, MD, MPH, FRCPC

Arch Intern Med. 2009;169(8):748-749.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cost-related nonadherence (CRN) is common, and one-third of older adults take less medication than prescribed to reduce out-of-pocket costs.1 Common strategies to reduce out-of-pocket costs include splitting pills, skipping doses, or delaying refills, all secondary forms of nonadherence.1 Less attention has been paid to "primary" nonadherence, ie, not even filling the prescription. This strategy is the most effective way to reduce out-of-pocket costs, and primary nonadherence is practiced by 10% to 20% of patients.2

Short of a randomized trial, the best way to understand the effect of out-of-pocket costs on primary or secondary nonadherence would be to undertake a large longitudinal study of older insured patients who are "exposed" to drug benefit plans of differing generosities and who go on to develop an incident diagnosis of a chronic condition that requires new treatment and then to measure the receipt of a prescription (under control . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill
Matthew D. Solomon, Dana P. Goldman, Geoffrey F. Joyce, and José J. Escarce
Arch Intern Med. 2009;169(8):740-748.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.